Industries de la santé
Johnson & Johnson Medical Devices Companies Acquire Orthotaxy to Develop Next-Generation Robotic-Assisted Surgery Platform in Orthopaedics
21 Février 2018
Orthotaxy’s Technology Will Be Leveraged to Develop Cost-Effective, Time-Efficient, User-Friendly Offering in a Broad Range of Orthopaedics Procedures |PARIS – February 20, 2018 – Johnson & Johnson Medical Devices Companies, through French affiliate Apsis S.A.S., announced today the acquisition of Orthotaxy, a privately-held developer of software-enabled surgery technologies...
Plus d'articles...
- DBV Technologies annonce les avancées réglementaires de Viaskin Peanut
- Servier et ImmunoQure AG signent un partenariat stratégique pour le développement d'un auto-anticorps humain anti-interféron-alpha
- US pharma industry holds to price-cap pledge
- Celgene’s acquisition of Juno Therapeutics puts the company in a good position to be a frontrunner in the CAR-T space